Suppr超能文献

“告诉我你的建议,我们就这么办,医生”:临床试验中非正式决策过程中的患者决策时间。

"Tell me what you suggest, and let's do that, doctor": Patient deliberation time during informal decision-making in clinical trials.

机构信息

Department of Public Policy, Human Genome Center, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.

出版信息

PLoS One. 2019 Jan 29;14(1):e0211338. doi: 10.1371/journal.pone.0211338. eCollection 2019.

Abstract

Informed consent is an essential part of an ethical clinical trial; to this end, researchers have developed several interventions to promote participants' full understanding of trials and thereby improve the consent process. However, few empirical studies have examined how patients make the decision of whether to give consent. The objective of this study, therefore, is to analyze patients' decision-making process when participating in clinical trials. We conduct an internet survey (n = 2,045) and interview data analysis (n = 40) with patients and categorize respondents into three types of participants: active, passive, and non-participation. Our results show that patients often make informal and quick decisions before medical staff provide them with relevant information during the informed consent process. For example, 55.9% of patients received initial information on clinical trials from an online article or web advertising, and 54.5% consulted no one about whether to participate in the clinical trial before making a decision. Only 20.7% of respondents subjectively spent time making the decision whether to participate; 43.0% of patients who said that they "spent time" coming to a decision took four or more days to reach a decision, while 8.3% of people who "did not spend time" making a decision took this among of time. Based on these results, we were able to break patients' decision-making process into four steps: first contact, informal decision making, relevant information, and formal decision making. Our results show that patients are most likely to make a decision based on the first information they receive on the clinical trial, whatever the source. To this end, having a list of questions for potential participants to ask researchers would be useful in helping better collecting information of clinical trials. In addition, research teams should give patients more than four days to decide between providing them with relevant information and obtaining written consent, even if the patient seems to make a quick decision.

摘要

知情同意是伦理临床试验的重要组成部分;为此,研究人员开发了几种干预措施,以促进参与者充分了解试验,从而改善同意过程。然而,很少有实证研究探讨患者如何做出是否同意的决定。因此,本研究的目的是分析患者参与临床试验时的决策过程。我们通过互联网调查(n=2045)和对患者的访谈数据分析(n=40),将受访者分为三种类型的参与者:积极参与者、被动参与者和不参与。我们的结果表明,患者在知情同意过程中,在医务人员提供相关信息之前,通常会做出非正式和快速的决定。例如,55.9%的患者从在线文章或网络广告中获得临床试验的初步信息,54.5%的患者在做出决定前没有咨询任何人是否参加临床试验。只有 20.7%的受访者主观上花费时间做出是否参与的决定;43.0%的表示“花时间”做出决定的患者需要四天或更长时间才能做出决定,而 8.3%的表示“不花时间”做出决定的患者则需要四天或更长时间才能做出决定。基于这些结果,我们能够将患者的决策过程分为四个步骤:第一接触、非正式决策、相关信息和正式决策。我们的结果表明,患者最有可能根据他们收到的关于临床试验的第一条信息做出决定,无论信息来源如何。为此,为潜在参与者列出一系列问题,让他们向研究人员提问,这将有助于更好地收集临床试验信息。此外,研究团队应该给患者四天以上的时间来决定是否提供相关信息并获得书面同意,即使患者似乎做出了快速决定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4e/6350979/14b038da6cf5/pone.0211338.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验